Legacy Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,851
Closed -$305K 141
2020
Q3
$305K Hold
3,851
0.12% 108
2020
Q2
$284K Buy
3,851
+288
+8% +$21.7K 0.12% 113
2020
Q1
$262K Buy
3,563
+26
+0.7% +$2.04K 0.13% 112
2019
Q4
$307K Hold
3,537
0.12% 115
2019
Q3
$284K Hold
3,537
0.12% 116
2019
Q2
$283K Sell
3,537
-264
-7% -$20.2K 0.13% 114
2019
Q1
$302K Buy
3,801
+264
+7% +$19.7K 0.14% 109
2018
Q4
$258K Hold
3,537
0.14% 112
2018
Q3
$239K Hold
3,537
0.11% 123
2018
Q2
$205K Buy
+3,537
New +$200K 0.1% 123
2017
Q4
Sell
-5,240
Closed -$320K 118
2017
Q3
$320K Hold
5,240
0.17% 92
2017
Q2
$320K Buy
5,240
+1,584
+43% +$96.4K 0.17% 94
2017
Q1
$222K Buy
3,656
+40
+1% +$2.43K 0.12% 104
2016
Q4
$204K Hold
3,616
0.12% 108
2016
Q3
$216K Sell
3,616
-21,828
-86% -$1.28M 0.14% 106
2016
Q2
$1.4M Buy
25,444
+251
+1% +$13.4K 0.87% 41
2016
Q1
$1.27M Buy
25,193
+2,116
+9% +$104K 0.82% 43
2015
Q4
$1.16M Sell
23,077
-744
-3% -$37.5K 0.75% 48
2015
Q3
$1.12M Buy
23,821
+2,725
+13% +$145K 0.76% 47
2015
Q2
$1.15M Buy
21,096
+691
+3% +$38.8K 0.75% 48
2015
Q1
$1.12M Buy
20,405
+105
+0.5% +$5.95K 0.71% 49
2014
Q4
$1.1M Buy
20,300
+3,605
+22% +$201K 0.7% 49
2014
Q3
$945K Sell
16,695
-524
-3% -$29.4K 0.63% 54
2014
Q2
$951K Sell
17,219
-1,886
-10% -$103K 0.62% 55
2014
Q1
$1.03M Sell
19,105
-1,362
-7% -$70.5K 0.73% 51
2013
Q4
$978K Buy
20,467
+2,211
+12% +$101K 0.7% 52
2013
Q3
$830K Sell
18,256
-419
-2% -$19.1K 0.62% 54
2013
Q2
$828K Buy
+18,675
New +$834K 0.63% 55

Other funds holding MRK

Legacy Capital Partners's MRK Position: Q4 2020 in Review

Legacy Capital Partners sold out of Merck (MRK) in Q4 2020, closing a stake of 3,851 shares — an estimated $305K sold.

Legacy Capital Partners first reported a position in MRK in Q2 2013 and held it in 28 quarters. The position peaked at $1.4M in Q2 2016. 2,708 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Legacy Capital Partners reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Legacy Capital Partners sold 3,851 Merck shares in Q4 2020, an estimated $305K.
  • Legacy Capital Partners first reported a position in Merck in Q2 2013 and held it in 28 quarters.
  • Legacy Capital Partners's Merck position peaked at $1.4M in Q2 2016.
  • 2,708 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Legacy Capital Partners's 13F filing for Q4 2020, filed 2 Feb 2021.